Sion, Mumbai, Maharashtra
- GST NO. : 27AQZPP9186B1ZZ
Twitter10 Kilogram (MOQ)
| Business Type | Manufacturer, Exporter, Supplier, Retailer |
Preferred Buyer From
| Location | Worldwide |
We are offering mefanamic acid.
systematic (iupac) name
2-(2,3-dimethylphenyl)aminobenzoic acid
cas number
61-68-7
formula
c15h15no2
mol. Mass
241.285 gmol
bioavailability : 90 %
protein binding : 90 %
mefenamic acid is a non-steroidal anti-inflammatory drug used to treat pain, including menstrual pain. It is typically prescribed for oral administration.
mefenamic acid decreases inflammation (swelling) and uterine contractions by a still unknown mechanism. However it is thought to be related to the inhibition of prostaglandin synthesis. There is also evidence that supports the use of mefenamic acid for perimenstrual migraine headache prophylaxis, with treatment starting 2 days prior to the onset of flow or 1 day prior to the expected onset of the headache and continuing for the duration of menstruation.[1]
since hepatic metabolism plays a significant role in mefenamic acid elimination, patients with known liver deficiency may be prescribed lower doses. Kidney deficiency may also cause accumulation of the drug and its metabolites in the excretory system. Therefore patients suffering from renal conditions should not be prescribed mefenamic acid.
Read More...
systematic (iupac) name
2-(2,3-dimethylphenyl)aminobenzoic acid
cas number
61-68-7
formula
c15h15no2
mol. Mass
241.285 gmol
bioavailability : 90 %
protein binding : 90 %
mefenamic acid is a non-steroidal anti-inflammatory drug used to treat pain, including menstrual pain. It is typically prescribed for oral administration.
mefenamic acid decreases inflammation (swelling) and uterine contractions by a still unknown mechanism. However it is thought to be related to the inhibition of prostaglandin synthesis. There is also evidence that supports the use of mefenamic acid for perimenstrual migraine headache prophylaxis, with treatment starting 2 days prior to the onset of flow or 1 day prior to the expected onset of the headache and continuing for the duration of menstruation.[1]
since hepatic metabolism plays a significant role in mefenamic acid elimination, patients with known liver deficiency may be prescribed lower doses. Kidney deficiency may also cause accumulation of the drug and its metabolites in the excretory system. Therefore patients suffering from renal conditions should not be prescribed mefenamic acid.
Looking for "Mefanamic Acid" ?
Kilogram
Explore More Products
